ClinVar Miner

Submissions for variant NM_024334.2(TMEM43):c.424G>C (p.Glu142Gln) (rs145619906)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000183957 SCV000236450 uncertain significance not provided 2018-12-20 criteria provided, single submitter clinical testing p.Glu142Gln (GAG>CAG): c.424 G>C in exon 5 of the TMEM43 gene (NM_024334.2). A variant of unknown significance has been identified in the TMEM43 gene. The E142Q variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. However, another variant at the same residue, E142K has been reported previously as a variant of unknown significance ( Haywood AFM et al., 2013; Baskin B et al., 2013). Haywood AFM et al. (2013) reported E142K in two unrelated UK patients and one population control sample in the homozygous state. Baskin B et al. (2013) reported E142K in a 47-year old female with minimal symptoms and no family history of ARVC who also harbored another variant of unknown significance in the DSP gene. In addition, 1000 Genomes Project identified E142K in 0.8%, 3/359 alleles from individuals of Hispanic ancestry. The E142Q variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, nor was it observed in the 1000 Genomes Project, indicating it is not a common benign variant in these populations. The E142Q variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species. However, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Mutations in nearby residues have not been reported in association with arrhythmia, indicating this region of the protein may tolerate change. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. The variant is found in ARRHYTHMIA panel(s).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.